Human Phenotype Ontology 
Grandparent Node:
expand
Abnormal blood cation concentration (HP:0010929)help
Parent Node:
expand
Abnormal blood transition element cation concentration (HP:0011030)help
..Starting node
..expand
Abnormality of iron homeostasis (HP:0011031)help
Term ID: 11031
Name: Abnormality of iron homeostasis
Synonym:
Definition: An abnormality of the homeostasis (concentration) of iron cation.
Comments:
Reference: HP:0011031
Genes and Diseases:
 
       Child Nodes:
........expandIncreased total iron binding capacity (HP:0025196) help
........expandAbnormal serum iron (HP:0040130) help
................... HP:0003452 Increased serum iron
................... HP:0040303 Decreased serum iron
........expandAbnormal serum ferritin (HP:0040133) help
................... HP:0003281 Increased serum ferritin
................... HP:0012343 Decreased serum ferritin
........expandAbnormal hepatic iron concentration (HP:0040134) help
................... HP:0012465 Elevated hepatic iron concentration
........expandAbnormal transferrin saturation (HP:0040135) help
................... HP:0012463 Elevated transferrin saturation
................... HP:0012464 Decreased transferrin saturation

 Sister Nodes: 
..expandAbnormal blood zinc concentration (HP:0008277) help
..expandAbnormal circulating copper concentration (HP:0010836) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0011031HP:0011031Abnormality of iron homeostasis0ABCD3 CL E G H582567OMIM:616278BILE ACID SYNTHESIS DEFECT, CONGENITAL, 5; CBAS55
HP:0011031HP:0011031Abnormality of iron homeostasis0ALAS2 CL E G H212397ORPHA:75563X-linked sideroblastic anemiaHP:0040281 - Very frequent72
HP:0011031HP:0011031Abnormality of iron homeostasis0BCS1L CL E G H6171020ORPHA:53693GRACILE syndrome72
HP:0011031HP:0011031Abnormality of iron homeostasis0BCS1L CL E G H6171020OMIM:603358GRACILE SYNDROME72
HP:0011031HP:0011031Abnormality of iron homeostasis0BMP2 CL E G H6501069OMIM:235200Hemochromatosis, type 113
HP:0011031HP:0011031Abnormality of iron homeostasis0BMP6 CL E G H6541073ORPHA:465508Symptomatic form of hemochromatosis type 1HP:0040281 - Very frequent
HP:0011031HP:0011031Abnormality of iron homeostasis0CARD9 CL E G H6417016391OMIM:212050Candidiasis, familial chronic mucocutaneous, autosomal recessive45
HP:0011031HP:0011031Abnormality of iron homeostasis0COL7A1 CL E G H12942214ORPHA:89842Autosomal recessive generalized dystrophic epidermolysis bullosa, intermediate form263
HP:0011031HP:0011031Abnormality of iron homeostasis0CP CL E G H13562295ORPHA:48818Aceruloplasminemia115
HP:0011031HP:0011031Abnormality of iron homeostasis0CP CL E G H13562295OMIM:604290ACERULOPLASMINEMIA115
HP:0011031HP:0011031Abnormality of iron homeostasis0FOXP1 CL E G H270863823ORPHA:391372Intellectual disability-severe speech delay-mild dysmorphism syndrome184
HP:0011031HP:0011031Abnormality of iron homeostasis0HAMP CL E G H5781715598ORPHA:79230Hemochromatosis type 2HP:0040281 - Very frequent15
HP:0011031HP:0011031Abnormality of iron homeostasis0HAMP CL E G H5781715598OMIM:613313Hemochromatosis, type 2B15
HP:0011031HP:0011031Abnormality of iron homeostasis0HBB CL E G H30434827ORPHA:231222Beta-thalassemia intermediaHP:0040282 - Frequent580
HP:0011031HP:0011031Abnormality of iron homeostasis0HBB CL E G H30434827ORPHA:231214Beta-thalassemia majorHP:0040282 - Frequent580
HP:0011031HP:0011031Abnormality of iron homeostasis0HBB CL E G H30434827ORPHA:231226Dominant beta-thalassemiaHP:0040283 - Occasional580
HP:0011031HP:0011031Abnormality of iron homeostasis0HFE CL E G H30774886OMIM:235200Hemochromatosis, type 138
HP:0011031HP:0011031Abnormality of iron homeostasis0HFE CL E G H30774886ORPHA:465508Symptomatic form of hemochromatosis type 1HP:0040281 - Very frequent38
HP:0011031HP:0011031Abnormality of iron homeostasis0HJV CL E G H1487384887ORPHA:79230Hemochromatosis type 2HP:0040281 - Very frequent
HP:0011031HP:0011031Abnormality of iron homeostasis0HJV CL E G H1487384887OMIM:602390Hemochromatosis, type 2A
HP:0011031HP:0011031Abnormality of iron homeostasis0KIF23 CL E G H94936392ORPHA:98870Congenital dyserythropoietic anemia type III1
HP:0011031HP:0011031Abnormality of iron homeostasis0PIGA CL E G H52778957ORPHA:447Paroxysmal nocturnal hemoglobinuria46
HP:0011031HP:0011031Abnormality of iron homeostasis0PKLR CL E G H53139020ORPHA:766Hemolytic anemia due to red cell pyruvate kinase deficiency51
HP:0011031HP:0011031Abnormality of iron homeostasis0RACGAP1 CL E G H291279804ORPHA:98870Congenital dyserythropoietic anemia type III
HP:0011031HP:0011031Abnormality of iron homeostasis0SKIC2 CL E G H649910898ORPHA:84064Syndromic diarrheaHP:0040283 - Occasional
HP:0011031HP:0011031Abnormality of iron homeostasis0SKIC2 CL E G H649910898OMIM:614602Trichohepatoenteric syndrome 2
HP:0011031HP:0011031Abnormality of iron homeostasis0SKIC3 CL E G H965223639ORPHA:84064Syndromic diarrheaHP:0040283 - Occasional
HP:0011031HP:0011031Abnormality of iron homeostasis0SKIC3 CL E G H965223639OMIM:222470Trichohepatoenteric syndrome 1.
HP:0011031HP:0011031Abnormality of iron homeostasis0SLC25A38 CL E G H5497726054OMIM:205950Anemia, sideroblastic, 2, pyridoxine-refractory41
HP:0011031HP:0011031Abnormality of iron homeostasis0SLC30A10 CL E G H5553225355ORPHA:309854Cirrhosis-dystonia-polycythemia-hypermanganesemia syndrome42
HP:0011031HP:0011031Abnormality of iron homeostasis0SLC30A10 CL E G H5553225355OMIM:613280Hypermanganesemia with dystonia 142
HP:0011031HP:0011031Abnormality of iron homeostasis0SLC40A1 CL E G H3006110909OMIM:606069Hemochromatosis, type 456
HP:0011031HP:0011031Abnormality of iron homeostasis0STEAP3 CL E G H5524024592OMIM:615234Anemia, hypochromic microcytic, with iron overload 21
HP:0011031HP:0011031Abnormality of iron homeostasis0STEAP3 CL E G H5524024592ORPHA:300298Severe congenital hypochromic anemia with ringed sideroblasts1
HP:0011031HP:0011031Abnormality of iron homeostasis0TFR2 CL E G H703611762OMIM:604250Hemochromatosis, type 367
HP:0011031HP:0011031Abnormality of iron homeostasis0TRNT1 CL E G H5109517341OMIM:616959Retinitis pigmentosa and erythrocytic microcytosis28
HP:0011031HP:0033212Abnormal total iron binding capacity1ABCD3 CL E G H582567OMIM:616278BILE ACID SYNTHESIS DEFECT, CONGENITAL, 5; CBAS55
HP:0011031HP:0040130Abnormal serum iron concentration1BCS1L CL E G H6171020OMIM:603358GRACILE SYNDROME72
HP:0011031HP:0040135Abnormal transferrin saturation1BCS1L CL E G H6171020ORPHA:53693GRACILE syndrome72
HP:0011031HP:0040130Abnormal serum iron concentration1BMP2 CL E G H6501069OMIM:235200Hemochromatosis, type 113
HP:0011031HP:0040135Abnormal transferrin saturation1BMP6 CL E G H6541073ORPHA:465508Symptomatic form of hemochromatosis type 1
HP:0011031HP:0040130Abnormal serum iron concentration1CARD9 CL E G H6417016391OMIM:212050Candidiasis, familial chronic mucocutaneous, autosomal recessive45
HP:0011031HP:0040130Abnormal serum iron concentration1COL7A1 CL E G H12942214ORPHA:89842Autosomal recessive generalized dystrophic epidermolysis bullosa, intermediate form263
HP:0011031HP:0040130Abnormal serum iron concentration1CP CL E G H13562295ORPHA:48818Aceruloplasminemia115
HP:0011031HP:0040130Abnormal serum iron concentration1CP CL E G H13562295OMIM:604290ACERULOPLASMINEMIA115
HP:0011031HP:0040130Abnormal serum iron concentration1FOXP1 CL E G H270863823ORPHA:391372Intellectual disability-severe speech delay-mild dysmorphism syndrome184
HP:0011031HP:0040135Abnormal transferrin saturation1HAMP CL E G H5781715598ORPHA:79230Hemochromatosis type 215
HP:0011031HP:0040135Abnormal transferrin saturation1HAMP CL E G H5781715598OMIM:613313Hemochromatosis, type 2B15
HP:0011031HP:0040130Abnormal serum iron concentration1HAMP CL E G H5781715598OMIM:613313Hemochromatosis, type 2B15
HP:0011031HP:0040130Abnormal serum iron concentration1HFE CL E G H30774886OMIM:235200Hemochromatosis, type 138
HP:0011031HP:0040135Abnormal transferrin saturation1HFE CL E G H30774886ORPHA:465508Symptomatic form of hemochromatosis type 138
HP:0011031HP:0040135Abnormal transferrin saturation1HJV CL E G H1487384887ORPHA:79230Hemochromatosis type 2
HP:0011031HP:0040130Abnormal serum iron concentration1HJV CL E G H1487384887OMIM:602390Hemochromatosis, type 2A
HP:0011031HP:0040130Abnormal serum iron concentration1KIF23 CL E G H94936392ORPHA:98870Congenital dyserythropoietic anemia type III1
HP:0011031HP:0033212Abnormal total iron binding capacity1KIF23 CL E G H94936392ORPHA:98870Congenital dyserythropoietic anemia type III1
HP:0011031HP:0040130Abnormal serum iron concentration1PIGA CL E G H52778957ORPHA:447Paroxysmal nocturnal hemoglobinuria46
HP:0011031HP:0040135Abnormal transferrin saturation1PKLR CL E G H53139020ORPHA:766Hemolytic anemia due to red cell pyruvate kinase deficiency51
HP:0011031HP:0040130Abnormal serum iron concentration1PKLR CL E G H53139020ORPHA:766Hemolytic anemia due to red cell pyruvate kinase deficiency51
HP:0011031HP:0040130Abnormal serum iron concentration1RACGAP1 CL E G H291279804ORPHA:98870Congenital dyserythropoietic anemia type III
HP:0011031HP:0033212Abnormal total iron binding capacity1RACGAP1 CL E G H291279804ORPHA:98870Congenital dyserythropoietic anemia type III
HP:0011031HP:0040130Abnormal serum iron concentration1SKIC2 CL E G H649910898OMIM:614602Trichohepatoenteric syndrome 2
HP:0011031HP:0040130Abnormal serum iron concentration1SKIC3 CL E G H965223639OMIM:222470Trichohepatoenteric syndrome 1
HP:0011031HP:0040135Abnormal transferrin saturation1SLC25A38 CL E G H5497726054OMIM:205950Anemia, sideroblastic, 2, pyridoxine-refractory41
HP:0011031HP:0040135Abnormal transferrin saturation1SLC30A10 CL E G H5553225355ORPHA:309854Cirrhosis-dystonia-polycythemia-hypermanganesemia syndromeHP:0040282 - Frequent42
HP:0011031HP:0033212Abnormal total iron binding capacity1SLC30A10 CL E G H5553225355ORPHA:309854Cirrhosis-dystonia-polycythemia-hypermanganesemia syndrome42
HP:0011031HP:0033212Abnormal total iron binding capacity1SLC30A10 CL E G H5553225355OMIM:613280Hypermanganesemia with dystonia 142
HP:0011031HP:0040135Abnormal transferrin saturation1SLC40A1 CL E G H3006110909OMIM:606069Hemochromatosis, type 456
HP:0011031HP:0040135Abnormal transferrin saturation1STEAP3 CL E G H5524024592OMIM:615234Anemia, hypochromic microcytic, with iron overload 21
HP:0011031HP:0040130Abnormal serum iron concentration1STEAP3 CL E G H5524024592ORPHA:300298Severe congenital hypochromic anemia with ringed sideroblasts1
HP:0011031HP:0040135Abnormal transferrin saturation1STEAP3 CL E G H5524024592ORPHA:300298Severe congenital hypochromic anemia with ringed sideroblasts1
HP:0011031HP:0040135Abnormal transferrin saturation1TFR2 CL E G H703611762OMIM:604250Hemochromatosis, type 367
HP:0011031HP:0040130Abnormal serum iron concentration1TFR2 CL E G H703611762OMIM:604250Hemochromatosis, type 367
HP:0011031HP:0040130Abnormal serum iron concentration1TRNT1 CL E G H5109517341OMIM:616959Retinitis pigmentosa and erythrocytic microcytosis28
HP:0011031HP:0033211Decreased total iron binding capacity2 CL E G H
HP:0011031HP:0025196Increased total iron binding capacity2ABCD3 CL E G H582567OMIM:616278BILE ACID SYNTHESIS DEFECT, CONGENITAL, 5; CBAS55
HP:0011031HP:0012464Decreased transferrin saturation2BCS1L CL E G H6171020ORPHA:53693GRACILE syndromeHP:0040281 - Very frequent72
HP:0011031HP:0003452Increased serum iron2BCS1L CL E G H6171020OMIM:603358GRACILE SYNDROME72
HP:0011031HP:0003452Increased serum iron2BMP2 CL E G H6501069OMIM:235200Hemochromatosis, type 1.13
HP:0011031HP:0012463Elevated transferrin saturation2BMP6 CL E G H6541073ORPHA:465508Symptomatic form of hemochromatosis type 1HP:0040281 - Very frequent
HP:0011031HP:0040303Decreased serum iron2CARD9 CL E G H6417016391OMIM:212050Candidiasis, familial chronic mucocutaneous, autosomal recessive45
HP:0011031HP:0040303Decreased serum iron2COL7A1 CL E G H12942214ORPHA:89842Autosomal recessive generalized dystrophic epidermolysis bullosa, intermediate formHP:0040282 - Frequent263
HP:0011031HP:0040303Decreased serum iron2CP CL E G H13562295ORPHA:48818AceruloplasminemiaHP:0040282 - Frequent115
HP:0011031HP:0040303Decreased serum iron2CP CL E G H13562295OMIM:604290ACERULOPLASMINEMIA.115
HP:0011031HP:0040303Decreased serum iron2FOXP1 CL E G H270863823ORPHA:391372Intellectual disability-severe speech delay-mild dysmorphism syndromeHP:0040283 - Occasional184
HP:0011031HP:0012463Elevated transferrin saturation2HAMP CL E G H5781715598ORPHA:79230Hemochromatosis type 2HP:0040281 - Very frequent15
HP:0011031HP:0012463Elevated transferrin saturation2HAMP CL E G H5781715598OMIM:613313Hemochromatosis, type 2B15
HP:0011031HP:0003452Increased serum iron2HAMP CL E G H5781715598OMIM:613313Hemochromatosis, type 2B.15
HP:0011031HP:0003452Increased serum iron2HFE CL E G H30774886OMIM:235200Hemochromatosis, type 1.38
HP:0011031HP:0012463Elevated transferrin saturation2HFE CL E G H30774886ORPHA:465508Symptomatic form of hemochromatosis type 1HP:0040281 - Very frequent38
HP:0011031HP:0012463Elevated transferrin saturation2HJV CL E G H1487384887ORPHA:79230Hemochromatosis type 2HP:0040281 - Very frequent
HP:0011031HP:0003452Increased serum iron2HJV CL E G H1487384887OMIM:602390Hemochromatosis, type 2A
HP:0011031HP:0025196Increased total iron binding capacity2KIF23 CL E G H94936392ORPHA:98870Congenital dyserythropoietic anemia type IIIHP:0040282 - Frequent1
HP:0011031HP:0003452Increased serum iron2KIF23 CL E G H94936392ORPHA:98870Congenital dyserythropoietic anemia type IIIHP:0040282 - Frequent1
HP:0011031HP:0040303Decreased serum iron2PIGA CL E G H52778957ORPHA:447Paroxysmal nocturnal hemoglobinuriaHP:0040282 - Frequent46
HP:0011031HP:0003452Increased serum iron2PKLR CL E G H53139020ORPHA:766Hemolytic anemia due to red cell pyruvate kinase deficiencyHP:0040282 - Frequent51
HP:0011031HP:0012463Elevated transferrin saturation2PKLR CL E G H53139020ORPHA:766Hemolytic anemia due to red cell pyruvate kinase deficiencyHP:0040283 - Occasional51
HP:0011031HP:0025196Increased total iron binding capacity2RACGAP1 CL E G H291279804ORPHA:98870Congenital dyserythropoietic anemia type IIIHP:0040282 - Frequent
HP:0011031HP:0003452Increased serum iron2RACGAP1 CL E G H291279804ORPHA:98870Congenital dyserythropoietic anemia type IIIHP:0040282 - Frequent
HP:0011031HP:0040303Decreased serum iron2SKIC2 CL E G H649910898OMIM:614602Trichohepatoenteric syndrome 2HP:0040283 - Occasional
HP:0011031HP:0003452Increased serum iron2SKIC3 CL E G H965223639OMIM:222470Trichohepatoenteric syndrome 1.HP:0003577 - Congenital onset
HP:0011031HP:0012463Elevated transferrin saturation2SLC25A38 CL E G H5497726054OMIM:205950Anemia, sideroblastic, 2, pyridoxine-refractory41
HP:0011031HP:0025196Increased total iron binding capacity2SLC30A10 CL E G H5553225355ORPHA:309854Cirrhosis-dystonia-polycythemia-hypermanganesemia syndromeHP:0040283 - Occasional42
HP:0011031HP:0025196Increased total iron binding capacity2SLC30A10 CL E G H5553225355OMIM:613280Hypermanganesemia with dystonia 142
HP:0011031HP:0012463Elevated transferrin saturation2SLC40A1 CL E G H3006110909OMIM:606069Hemochromatosis, type 456
HP:0011031HP:0012463Elevated transferrin saturation2STEAP3 CL E G H5524024592OMIM:615234Anemia, hypochromic microcytic, with iron overload 21
HP:0011031HP:0012464Decreased transferrin saturation2STEAP3 CL E G H5524024592ORPHA:300298Severe congenital hypochromic anemia with ringed sideroblastsHP:0040281 - Very frequent1
HP:0011031HP:0003452Increased serum iron2STEAP3 CL E G H5524024592ORPHA:300298Severe congenital hypochromic anemia with ringed sideroblastsHP:0040282 - Frequent1
HP:0011031HP:0003452Increased serum iron2TFR2 CL E G H703611762OMIM:604250Hemochromatosis, type 3.67
HP:0011031HP:0012463Elevated transferrin saturation2TFR2 CL E G H703611762OMIM:604250Hemochromatosis, type 367
HP:0011031HP:0040303Decreased serum iron2TRNT1 CL E G H5109517341OMIM:616959Retinitis pigmentosa and erythrocytic microcytosis28


Genes (25) :ABCD3 ALAS2 BCS1L BMP2 BMP6 CARD9 COL7A1 CP FOXP1 HAMP HBB HFE HJV KIF23 PIGA PKLR RACGAP1 SKIC2 SKIC3 SLC25A38 SLC30A10 SLC40A1 STEAP3 TFR2 TRNT1

Diseases (31) :OMIM:616278 ORPHA:75563 ORPHA:53693 OMIM:603358 OMIM:235200 ORPHA:465508 OMIM:212050 ORPHA:89842 ORPHA:48818 OMIM:604290 ORPHA:391372 ORPHA:79230 OMIM:613313 ORPHA:231222 ORPHA:231214 ORPHA:231226 OMIM:602390 ORPHA:98870 ORPHA:447 ORPHA:766 ORPHA:84064 OMIM:614602 OMIM:222470 OMIM:205950 ORPHA:309854 OMIM:613280 OMIM:606069 OMIM:615234 ORPHA:300298 OMIM:604250 OMIM:616959
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.